Opportunistic infection (OI) in recipients of CD34-selected (CD34+) and unselected (UNS) autologous hematopoietic stem cell transplantation (AHSCT) for non-Hodgkin's lymphoma (NHL).

被引：0
|
作者：
Raad, JY [1 ]
Hurd, DD [1 ]
Cruz, J [1 ]
Perry, J [1 ]
Radford, J [1 ]
Dodge, W [1 ]
High, KP [1 ]
机构：
[1] Wake Forest Univ, Sch Med, Dept Internal Med, Hematol Oncol Sect, Winston Salem, NC 27109 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4926
引用
收藏
页码：380B / 380B
页数：1
相关论文
共 50 条
  • [41] Unselected autologous followed by CD34+selected peripheral blood stem cell transplantation for multiple myeloma
    Sorà, F
    De Stefano, V
    Chiusolo, P
    Laurenti, L
    Rossi, E
    Piccirillo, N
    Di Mario, A
    Palladino, M
    Leone, G
    Sica, S
    BONE MARROW TRANSPLANTATION, 2004, 33 : S356 - S356
  • [42] Selection and transplantation of autologous CD34+ peripheral blood stem cells in non-Hodgkin's lymphoma using high-speed fluorescence-activated cell sorting.
    Holland, HK
    Fleming, WH
    Waller, EK
    Geller, RB
    Connaghan, DG
    Devine, SD
    Yeager, AM
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 631 - 631
  • [43] Peripheral blood CD34+ cell count as a predictor of adequacy of hematopoietic stem cell collection for autologous transplantation
    Combariza, Juan F.
    Barco, Gloria
    Estrada, Angela
    Jaramillo, Sergio
    Arango, Marcos
    IATREIA, 2016, 29 (04) : 424 - 432
  • [44] The impact of CD34+ cell dose and comorbidities on engraftment following autologous hematopoietic stem cell transplantation (ASCT).
    Fiala, Mark A.
    Bhamidipati, Pavan Kumar
    Wang, Stephanie
    Sturgill, Trisha
    Gao, Feng
    Abboud, Camille N.
    Cashen, Amanda F.
    Jacoby, Meagan A.
    Pusic, Iskra
    Romee, Rizwan
    Schroeder, Mark A.
    Uy, Geoffrey L.
    Vij, Ravi
    Westervelt, Peter
    DiPersio, John F.
    Stockeri-Goldstein, Keith
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation?
    M Y Ali
    Y Oyama
    J Monreal
    J N Winter
    M S Tallman
    S F Williams
    S Singhal
    L I Gordon
    J Mehta
    Bone Marrow Transplantation, 2003, 31 : 861 - 864
  • [46] Autologous blood stem cell transplantation with CeprateR selected CD34+ cells for multiple myeloma.
    Volin, L
    Juvonen, E
    Elonen, E
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 1998, 21 : S204 - S204
  • [47] Transplantation of highly purified CD34+Thy-I+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma
    Vose, JM
    Bierman, PJ
    Lynch, JC
    Atkinson, K
    Juttner, C
    Hanania, E
    Bociek, G
    Armitage, JO
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (12) : 680 - 687
  • [48] CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma
    Smith, Eric
    Devlin, Sean M.
    Kosuri, Satyajit
    Orlando, Evelyn
    Landau, Heather
    Lesokhin, Alex M.
    Chung, David J.
    Hassoun, Hani
    Lendvai, Nikoletta
    Landgren, Ola
    Giralt, Sergio
    Chari, Ajai
    Jagannath, Sundar
    Koehne, Guenther
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (02) : 258 - 267
  • [49] Virus reactivation in high-risk non-Hodgkin's lymphoma patients after autologous CD34+-selected peripheral blood progenitor cell transplantation
    Lin, Peng-Chan
    Lee, Ming-Yang
    Lin, Jen-Tsun
    Hsiao, Liang-Tsai
    Chen, Po-Min
    Chiou, Tzeon-Jye
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 87 (04) : 434 - 439
  • [50] Virus reactivation in high-risk non-Hodgkin’s lymphoma patients after autologous CD34+-selected peripheral blood progenitor cell transplantation
    Peng-Chan Lin
    Ming-Yang Lee
    Jen-Tsun Lin
    Liang-Tsai Hsiao
    Po-Min Chen
    Tzeon-Jye Chiou
    International Journal of Hematology, 2008, 87 : 434 - 439
12345